Hormone Replacement Therapy Market By Therapy Type (Human Growth Hormone (HGH) Replacement Therapy, Testosterone Replacement Therapy, Thyroid Replacement Therapy, Estrogen Replacement Therapy), By Application (Growth Hormone Deficiency, Menopause, Hypothyroidism, Male Hypogonadism, and Others), By Route of Administration (Oral, Parenteral, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and By Region - Trends, Analysis and Forecast till 2030

Throughout the forecast period, the strong pipeline of innovative hormone replacement treatments that are currently being developed and are anticipated to receive approval soon is anticipated to be a key driver of market growth. TherapeuticsMD, Inc., for example, announced in March 2018 that the FDA in the United States had accepted its New Drug Application (NDA) for TX-001HR, an oral hormone combination therapy, to treat moderate-to-severe vasomotor symptoms associated with menopause. In addition, the high frequency of hormone-related disorders is anticipated to play a significant role in the market's expansion due to the growing demand for hormone replacement therapies. For example, the American Thyroid Association (ATA) estimates that over 12 percent of Americans will experience approximately 20 million Americans suffer from a thyroid ailment at some point in their lives.